Experimental vaginal treatment tested for early cervical abnormalities
Disease control
Terminated
This study tested whether a vaginal insert called ABI-2280 could safely treat precancerous cervical lesions caused by HPV. Women aged 25-55 with confirmed cervical abnormalities self-administered the treatment. Researchers measured safety, side effects, and whether the treatment …
Phase: PHASE1, PHASE2 • Sponsor: Antiva Biosciences • Aim: Disease control
Last updated Apr 01, 2026 23:41 UTC